Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sodium bicarbonate for AKI prevention in COVID-19
NCT04806061Active, not recruiting
- Sponsor
- Guy's and St Thomas' NHS Foundation Trust
- Start
- Oct 2021
- Primary completion
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of sodium bicarbonate in acute kidney injury (AKI), sponsored by Guy's and St Thomas' NHS Foundation Trust. Primary endpoint: Urinary alkalisation at 10 days. Started Oct 2021; status: active, not recruiting.
02
Drugs
sodium bicarbonate
03
Conditions
acute kidney injury (AKI)
Beyond the preview
Go deeper on NCT04806061.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04806061.